These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Precipitating/aggravating factors of porphyria cutanea tarda in Spanish patients. Cruz-Rojo J, Fontanellas A, Morán-Jiménez MJ, Navarro-Ordóñez S, García-Bravo M, Méndez M, Muñoz-Rivero MC, de Salamanca RE. Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):845-52. PubMed ID: 12699242 [Abstract] [Full Text] [Related]
24. Porphyria cutanea tarda associated with Cys282Tyr mutation in HFE gene in hereditary hemochromatosis: a case report and review of the literature. Young LC. Cutis; 2007 Nov; 80(5):415-8. PubMed ID: 18189029 [Abstract] [Full Text] [Related]
25. Hemochromatosis gene sequence deviations in German patients with porphyria cutanea tarda. Frank J, Poblete-Gutiérrez P, Weiskirchen R, Gressner O, Merk HF, Lammert F. Physiol Res; 2006 Nov; 55 Suppl 2():S75-83. PubMed ID: 17298224 [Abstract] [Full Text] [Related]
26. Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency. Egger NG, Goeger DE, Payne DA, Miskovsky EP, Weinman SA, Anderson KE. Dig Dis Sci; 2002 Feb; 47(2):419-26. PubMed ID: 11855561 [Abstract] [Full Text] [Related]
29. The role of inherited and acquired factors in the development of porphyria cutanea tarda in the Argentinean population. Méndez M, Rossetti MV, Del C Batlle AM, Parera VE. J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):417-24. PubMed ID: 15761419 [Abstract] [Full Text] [Related]
30. [Hepatitis C, hemochromatosis and porphyria cutanea tarda]. Teubner A, Richter M, Schuppan D, Köstler E, Stölzel U. Dtsch Med Wochenschr; 2006 Mar 31; 131(13):691-5. PubMed ID: 16555178 [Abstract] [Full Text] [Related]
31. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis. Aguilar-Martinez P, Esculié-Coste C, Bismuth M, Giansily-Blaizot M, Larrey D, Schved JF. Blood Cells Mol Dis; 2001 Mar 31; 27(1):290-3. PubMed ID: 11358390 [Abstract] [Full Text] [Related]
33. Frequency of the hemochromatosis HFE mutations C282Y, H63D, and S65C in blood donors in the Faroe Islands. Milman N, á Steig T, Koefoed P, Pedersen P, Fenger K, Nielsen FC. Ann Hematol; 2005 Mar 31; 84(3):146-9. PubMed ID: 15042317 [Abstract] [Full Text] [Related]
34. Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma. Fracanzani AL, Fargion S, Stazi MA, Valenti L, Amoroso P, Cariani E, Sangiovanni A, Tommasini M, Rossini A, Bertelli C, Fatta E, Patriarca V, Brescianini S, Stroffolini T. Blood Cells Mol Dis; 2005 Mar 31; 35(1):27-32. PubMed ID: 15894495 [Abstract] [Full Text] [Related]
35. HFE haemochromatosis gene mutations in liver transplant patients. Halme L, Heliö T, Mäkinen J, Höckerstedt K, Färkkilä M, Piippo K, Krusius T, Kontula K. Scand J Gastroenterol; 2001 Aug 31; 36(8):881-5. PubMed ID: 11495086 [Abstract] [Full Text] [Related]
36. Are hepatitis C infection and C282Y mutation in hemochromatosis gene independent factors for Porphyria cutanea tarda? Malina L, Zdárský E, Stránský J, Dandová S, Michalíková H. Dermatology; 2002 Aug 31; 205(1):76-7. PubMed ID: 12145444 [No Abstract] [Full Text] [Related]
37. [Mutations in the HFE gene in patients with rheumatic diseases]. Půtová I, Cimburová M, Jarosová K, Vencovský J, Horák J. Cas Lek Cesk; 2005 Aug 31; 144(6):391-7; discussion 397-8. PubMed ID: 16047841 [Abstract] [Full Text] [Related]
38. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism. Njajou OT, Houwing-Duistermaat JJ, Osborne RH, Vaessen N, Vergeer J, Heeringa J, Pols HA, Hofman A, van Duijn CM. Eur J Hum Genet; 2003 Mar 31; 11(3):225-31. PubMed ID: 12673276 [Abstract] [Full Text] [Related]
40. An open population screening study for HFE gene major mutations proves the low prevalence of C282Y mutation in Central Italy. Floreani A, Rosa Rizzotto E, Basso D, Navaglia F, Zaninotto M, Petridis I, DI Andrea O, Testa R, Marra M, Baldo V, Chiaramonte M. Aliment Pharmacol Ther; 2007 Aug 15; 26(4):577-86. PubMed ID: 17661761 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]